Reviewing Cresco Labs (OTCMKTS:CRLBF) & Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ)

Cresco Labs (OTCMKTS:CRLBF) and Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

Earnings and Valuation

This table compares Cresco Labs and Rock Creek Pharmaceuticals”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cresco Labs	$770.89 million	0.49	-$175.52 million	($0.22)	-3.54
Rock Creek Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Rock Creek Pharmaceuticals has lower revenue, but higher earnings than Cresco Labs.

Profitability

This table compares Cresco Labs and Rock Creek Pharmaceuticals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cresco Labs	-9.15%	-16.52%	-4.81%
Rock Creek Pharmaceuticals	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Cresco Labs and Rock Creek Pharmaceuticals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cresco Labs	0	2	1	2	3.00
Rock Creek Pharmaceuticals	0	0	0	0	0.00

Cresco Labs currently has a consensus target price of $3.00, suggesting a potential upside of 284.71%. Given Cresco Labs’ stronger consensus rating and higher possible upside, analysts plainly believe Cresco Labs is more favorable than Rock Creek Pharmaceuticals.

Institutional & Insider Ownership

0.1% of Cresco Labs shares are held by institutional investors. 0.9% of Rock Creek Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Cresco Labs beats Rock Creek Pharmaceuticals on 6 of the 10 factors compared between the two stocks.

About Cresco Labs

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.

About Rock Creek Pharmaceuticals

Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL.